Abstract
We describe here a protocol for labelling autologous white blood cells with (111)In-oxine based on previously published consensus papers and guidelines. This protocol includes quality control and safety procedures and is in accordance with current European Union regulations and International Atomic Energy Agency recommendations.
MeSH terms
-
Adult
-
Cell Separation / methods
-
Chemotaxis, Leukocyte
-
Child, Preschool
-
Humans
-
Indium Radioisotopes* / pharmacokinetics
-
Infections / diagnostic imaging
-
Inflammation / diagnostic imaging
-
Isotope Labeling / methods*
-
Leukocytes*
-
Organometallic Compounds* / pharmacokinetics
-
Oxyquinoline / analogs & derivatives*
-
Oxyquinoline / pharmacokinetics
-
Radiation Protection / legislation & jurisprudence
-
Radiation Protection / methods
-
Radionuclide Imaging
-
Radiopharmaceuticals* / pharmacokinetics
-
Tissue Distribution
Substances
-
Indium Radioisotopes
-
Organometallic Compounds
-
Radiopharmaceuticals
-
indium oxine
-
Oxyquinoline